Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Batist

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
NPJ Precision Oncology|February 7, 2025
An automatic pipeline for temporal monitoring of radiotherapy-induced toxicities in head and neck cancer patientsParsa Bagherzadeh, Khalil Sultanem, Gerald Batist, et al.
The Journal of Biological Chemistry|March 26, 2005
Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymesWeimin Miao, Lianggao Hu, P James Scrivens, et al.
Cancer Investigation|April 9, 2004
The role of surrogate markers in the clinical development of antiretroviral therapy: a model for early evaluation of targeted cancer drugsMarco Petrella, Julio Montaner, Gerald Batist, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 12, 2007
Novel use of the fluorescent dye 5-(and-6)-chloromethyl SNARF-1 acetate for the measurement of intracellular glutathione in leukemic cells and primary lymphocytesDavid Hamilton, Martin Loignon, Moulay A Alaoui-Jamali, et al.
Expert Opinion on Pharmacotherapy|December 11, 2002
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapyGerald Batist, Jeremy Barton, Philip Chaikin, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2022
Immuno-MALDI-MS for Accurate Quantitation of Targeted Peptides from Volume-Restricted SamplesConstance A Sobsey, Bjoern Froehlich, Gerald Batist, et al.
The Journal of Biological Chemistry|October 28, 2016
Nrf2 Transcription Factor Can Directly Regulate mTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITYGabriel Bendavit, Tahar Aboulkassim, Khalid Hilmi, et al.
Discovery Medicine|July 31, 2010
The biology of melanoma prognostic factorsAlan Spatz, Nathalie Stock, Gerald Batist, et al.
Biochemical Pharmacology|May 8, 2004
A cell-based system to identify and characterize the molecular mechanism of drug-metabolizing enzyme (DME) modulatorsWeimin Miao, Lianggao Hu, Mustapha Kandouz, et al.
Blood|March 29, 2003
A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione productionDavid Hamilton, Jian Hui Wu, Moulay Alaoui-Jamali, et al.
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
NPJ Precision Oncology|February 7, 2025
An automatic pipeline for temporal monitoring of radiotherapy-induced toxicities in head and neck cancer patientsParsa Bagherzadeh, Khalil Sultanem, Gerald Batist, et al.
The Journal of Biological Chemistry|March 26, 2005
Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymesWeimin Miao, Lianggao Hu, P James Scrivens, et al.
Cancer Investigation|April 9, 2004
The role of surrogate markers in the clinical development of antiretroviral therapy: a model for early evaluation of targeted cancer drugsMarco Petrella, Julio Montaner, Gerald Batist, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 12, 2007
Novel use of the fluorescent dye 5-(and-6)-chloromethyl SNARF-1 acetate for the measurement of intracellular glutathione in leukemic cells and primary lymphocytesDavid Hamilton, Martin Loignon, Moulay A Alaoui-Jamali, et al.
Expert Opinion on Pharmacotherapy|December 11, 2002
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapyGerald Batist, Jeremy Barton, Philip Chaikin, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2022
Immuno-MALDI-MS for Accurate Quantitation of Targeted Peptides from Volume-Restricted SamplesConstance A Sobsey, Bjoern Froehlich, Gerald Batist, et al.
The Journal of Biological Chemistry|October 28, 2016
Nrf2 Transcription Factor Can Directly Regulate mTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITYGabriel Bendavit, Tahar Aboulkassim, Khalid Hilmi, et al.
Discovery Medicine|July 31, 2010
The biology of melanoma prognostic factorsAlan Spatz, Nathalie Stock, Gerald Batist, et al.
Biochemical Pharmacology|May 8, 2004
A cell-based system to identify and characterize the molecular mechanism of drug-metabolizing enzyme (DME) modulatorsWeimin Miao, Lianggao Hu, Mustapha Kandouz, et al.
Blood|March 29, 2003
A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione productionDavid Hamilton, Jian Hui Wu, Moulay Alaoui-Jamali, et al.
Pageof 17